Live Attenuated Vaccines Market is expected to reach US$ 31.56 Billion by 2033 | Major Companies - GlaxoSmithKline Plc, Merck & Co., Inc., Johnson & Johnson, Sanofi.

Market Size and Growth:

The Global Live Attenuated Vaccines Market size reached US$ 16.80 Billion in 2023, with a rise of US$ 17.82 Billion in 2024 and is expected to reach US$ 31.56 Billion by 2033, growing at a CAGR of 6.6% during the forecast period 2025-2033.

The Live Attenuated Vaccines Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/live-attenuated-vaccines-market?sz

The Live Attenuated Vaccines Market refers to the global industry focused on developing, manufacturing, and distributing vaccines made from weakened forms of pathogens. These vaccines stimulate strong, long-lasting immune responses and are widely used to prevent infectious diseases such as measles, mumps, rubella, polio, influenza, and tuberculosis across pediatric and adult populations.

Recent Key Developments of United States:

✅ December 2025: The reconstituted ACIP discussed potential changes to vaccine schedules, including reviews of live attenuated vaccines like LAIV, during its December 4-5 meeting, influencing future immunization policies.

✅ November 2025: CDC surveillance reported five additional influenza-associated pediatric deaths in week 51, totaling eight for the 2025-2026 season, highlighting ongoing demand for live attenuated influenza vaccines (LAIV) amid active flu circulation.

✅ October 2025: The Paul-Ehrlich-Institut released over 18.5 million doses of influenza vaccines, including live attenuated options, for the 2025/2026 season by mid-October to support early vaccination efforts.

Recent Key Developments of Europe:

✅ December 2025: EMA's CHMP meeting on December 8-11 reviewed vaccine authorizations but reported no new live attenuated approvals; however, early influenza vaccine effectiveness estimates were issued against rising A(H3N2) activity.

✅ November 2025: Vaccines Europe announced 91 innovative vaccines in development by member companies on December 1, including live attenuated platforms, as part of their 2025 pipeline review emphasizing disease prevention.

✅ October 2025: EMA noted updates to Rotarix, a live attenuated rotavirus vaccine, on December 19 reflecting ongoing assessments, with prior October activities tied to seasonal vaccine preparations.

List of the Key Players in the Live Attenuated Vaccines Market:

GlaxoSmithKline Plc
Merck & Co., Inc.
Johnson & Johnson
Sanofi
CSL Limited
Serum Institute of India Pvt. Ltd.
AstraZeneca
Bavarian Nordic Inc
BioDiem
Bharat Biotech

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/live-attenuated-vaccines-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Live Attenuated Vaccines Market:

By Type: Viral, Bacterial.

By Indication: Tuberculosis, Measles, Rotavirus, Yellow Fever, Oral Polio, Others.

By Route of Administration: Oral, Injectable, Intranasal.

By Age Group: Pediatrics, Adolescents, Adults, Geriatrics.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=live-attenuated-vaccines-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Live Attenuated Vaccines market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Live Attenuated Vaccines Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Live Attenuated Vaccines market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Live Attenuated Vaccines Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Live Attenuated Vaccines Market in 2025?
◆ What is the projected growth rate of the Live Attenuated Vaccines Market through 2033?
◆ Who are the key players in the Live Attenuated Vaccines Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.